# Magenta Elevate™ EFS in High-Risk PCI Patients

> **NCT05727059** · NA · COMPLETED · sponsor: **Magenta Medical Ltd.** · enrollment: 18 (actual)

## Conditions studied

- High-risk Percutaneous Coronary Intervention

## Interventions

- **DEVICE:** The Elevate™ System

## Key facts

- **NCT ID:** NCT05727059
- **Lead sponsor:** Magenta Medical Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-05-08
- **Primary completion:** 2023-12-01
- **Final completion:** 2024-01-02
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2024-09-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05727059

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05727059, "Magenta Elevate™ EFS in High-Risk PCI Patients". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05727059. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*